Dr. Michael Birrer

Dr. Michael Birrer, MD, PhD, is a nationally recognized gynecologic oncologist specializing in ovarian and other gynecologic malignancies. He serves as Director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, where he also holds the position of Vice Chancellor. Dr. Birrer earned his MD and PhD degrees from Albert Einstein College of Medicine and completed residency training in internal medicine at Massachusetts General Hospital. He pursued fellowship training in medical oncology at the National Cancer Institute. He is board-certified in Internal Medicine and Medical Oncology and is widely acknowledged for his expertise in translational research in ovarian cancer.

Dr. Birrer’s research focuses on identifying molecular mechanisms of ovarian cancer pathogenesis and resistance, with the goal of developing novel targeted therapies. He has led numerous clinical trials and translational studies that have advanced the understanding of biomarkers and therapeutic targets in gynecologic malignancies. He has published extensively in high-impact journals, contributing to the field’s evolving standards of care. His work has had a major influence on the design of precision oncology trials and on shaping future strategies for ovarian cancer treatment.

In addition to his clinical and research leadership, Dr. Birrer is an experienced educator and mentor. He has trained fellows, residents, and junior investigators, many of whom have gone on to significant academic and clinical careers. He has held leadership roles in cooperative oncology groups and national organizations, contributing to guideline development and translational research infrastructure. Through his commitment to scientific innovation, patient care, and mentorship, Dr. Michael Birrer continues to lead efforts that are improving outcomes for women with gynecologic cancers.